AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2025
Mar 5, 2025
30786_dirs_2025-03-05_fa7baf0f-64c9-468d-84f5-406c72714d0b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO BIO.B)
CIK: 0000012208
Period of Report: 2025-03-03
Reporting Person: COREY COLLEEN (EVP, Global Human Resources)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-03 | Non-Qualified Stock Option (right to buy) | $256.45 | A | 1946 | Acquired | 2035-03-03 | Bio-Rad A Common Stock (1946) | Direct |
Footnotes
F1: The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Share Issue/Capital Change
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Earnings Release
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13